blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1667634

EP1667634 - ANTHRAX VACCINE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  23.07.2010
Database last updated on 03.10.2024
Most recent event   Tooltip23.07.2010Application deemed to be withdrawnpublished on 25.08.2010  [2010/34]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
[2010/10]
Former [2006/24]For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue Rahway
New Jersey 07065-0907 / US
Inventor(s)01 / CAULFIELD, Michael, J.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
02 / COOK, James, C., III
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
03 / JOYCE, Joseph, G.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
 [2006/24]
Representative(s)Man, Jocelyn, et al
Merck & Co., Inc.
European Patent Department
Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU / GB
[N/P]
Former [2006/48]Man, Jocelyn, et al
Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU / GB
Former [2006/24]Man, Jocelyn, et al
Merck & Co.,Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date04817743.030.07.2004
[2006/24]
WO2004US25033
Priority number, dateUS20030491478P30.07.2003         Original published format: US 491478 P
[2006/24]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005048918
Date:02.06.2005
Language:EN
[2005/22]
Type: A2 Application without search report 
No.:EP1667634
Date:14.06.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 02.06.2005 takes the place of the publication of the European patent application.
[2006/24]
Search report(s)International search report - published on:US31.05.2007
(Supplementary) European search report - dispatched on:EP31.01.2008
ClassificationIPC:A61K39/385, A61K39/02, A61K39/116, A61K39/07, A61K38/16
[2007/31]
CPC:
A61K39/07 (EP,US); A61K39/095 (EP,US); C07K14/32 (EP,US);
A61K2039/55505 (EP,US); A61K2039/6068 (EP,US); A61K2039/70 (EP,US)
Former IPC [2006/24]A61K6/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/24]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:ANTHRAX-VAKZINE[2006/24]
English:ANTHRAX VACCINE[2006/24]
French:VACCIN CONTRE L'ANTHRAX[2006/24]
Entry into regional phase28.02.2006National basic fee paid 
28.02.2006Search fee paid 
30.11.2007Designation fee(s) paid 
30.11.2007Examination fee paid 
Examination procedure25.01.2006Amendment by applicant (claims and/or description)
30.11.2007Examination requested  [2008/03]
14.07.2008Despatch of a communication from the examining division (Time limit: M06)
11.05.2009Reply to a communication from the examining division
19.10.2009Despatch of a communication from the examining division (Time limit: M04)
02.03.2010Application deemed to be withdrawn, date of legal effect  [2010/34]
08.04.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/34]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
11.05.2009Request for further processing filed
11.05.2009Full payment received (date of receipt of payment)
Fees paidRenewal fee
10.07.2006Renewal fee patent year 03
04.07.2007Renewal fee patent year 04
27.03.2008Renewal fee patent year 05
08.07.2009Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]WO2005000884  (US GOV HEALTH & HUMAN SERV [US], et al) [E] 1-3,5,7,10 * page 2, line 5 - line 12 * * page 6, line 26 - page 7, line 6 * * page 12, line 35 - page 15, line 27 * * page 20, line 20 - page 27, line 12; example - *;
 [E]WO2005007804  (HARVARD COLLEGE [US], et al) [E] 1-3,5,7,9,10 * page 2, line 20 - page 4, line 23 ** page 6, line 2 - page 7, line 30; example - *;
 [DX]  - RACHEL SCHNEERSON ET AL., "Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: A potential addition to the anthrax vaccine", PNAS, (20030722), vol. 100, no. 15, pages 8945 - 8950, XP002306072 [DX] 1-3,5-7,10 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.1633512100
 [X]  - GEORGE SENYK ET AL., "The immune response to Glucagon in conjugated form", IMMUNOCHEMISTRY, (1972), vol. 9, pages 97 - 110, XP009039720 [X] 1-3 * page 98, paragraph L - page 99, paragraph 1 * * page 107, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/0019-2791(72)90031-6
 [A]  - ELIZABETH C. KING ET AL., "Covalent modification in aqueous solution of Poly-gamma-D-Glutamic acid from Bacillus licheniformis", JOURNAL OF POLYMER SCIENCE PART A: POLYMER CHEMISTRY, (1998), vol. 36, pages 1995 - 1999, XP003011146 [A] 1-6 * the whole document *

DOI:   http://dx.doi.org/10.1002/(SICI)1099-0518(19980915)36:12<1995::AID-POLA4>3.0.CO;2-N
 [PX]  - GI-EUN RHIE ET AL., "A dually active anthrax vaccine that confers protection against both bacilli and toxins", PNAS, (20030916), vol. 100, no. 19, pages 10925 - 10930, XP002306076 [PX] 1,5,7,10 * abstract * * page 1095, column R, paragraph 2 * * page 10925, column R, paragraph L - page 1096, column L, paragraph 1 * * page 10926, column L, paragraph 3 * * page 10927, column L, paragraph 2 *

DOI:   http://dx.doi.org/10.1073/pnas.1834478100
 [PX]  - EMMANUEL PRODHOMME ET AL., "Multivalent conjugates of Poly-gamma-D-glutamic acid from Bacillus licheniformis with antibody F(ab') and glycopeptide ligands", BIOCONJUGATE CHEMISTRY, (20031106), vol. 14, pages 1148 - 1155, XP003001051 [PX] 1-3 * abstract * * page 1148, column R, paragraph 3 - page 1153, column R, paragraph 2 *
International search[X]  - PRODHOMME J.-P.F. ET AL., "Poly gamma-D-glutamic acid as a template forfunctionalized water-soluble biomaterials", ABSTRACTS OF THE 219TH ACS NATIONAL MEETING, SAN FRANCISCO, CA, AMERICAN CHEMICAL SOCIETY, WASHINGTON D.C. # 133, (20000326), XP009039728
 [XP]  - PRODHOMME E.J.F. ET AL., "Multivalent conjugates of poly-gamma-D-glutamic acid from Bacillus licheniformis with antibody F(ab') and glycopeptide ligands", BIOCONJUGATE CHEM., (200311), vol. 14, pages 1148 - 1155, XP003001051
 [Y]  - GOODMAN J.W. ET AL., "Immunochemical studies on the poly-gamma-D-glutamyl capsulae of Bacillus anthracis. III. The activity with rabbit antisera of peptides derived from the homologous polypeptide", BIOCHEMISTRY, (196802), vol. 7, no. 2, pages 706 - 710, XP001203672

DOI:   http://dx.doi.org/10.1021/bi00852a013
 [Y]  - SENYK G. ET AL., "The immune response to glucagon in conjugated form", IMMUNOCHEMISTRY, (1972), vol. 9, pages 97 - 110, XP009039720

DOI:   http://dx.doi.org/10.1016/0019-2791(72)90031-6
 [XP]  - RHIE G. ET AL., "A dually active anthrax vaccine that confers protection against both bacilli and toxins", PNAS, (20030916), vol. 100, no. 19, pages 10925 - 10930, XP002306076

DOI:   http://dx.doi.org/10.1073/pnas.1834478100
 [A]  - KING E.C. ET AL., "Covalent modification in aqueous solution of poly-gamma-D-glutamic acid from Bacillus licheniformis", J. POLYMER SCI. PART A, (199809), vol. 36, no. 12, pages 1995 - 1999, XP003011146

DOI:   http://dx.doi.org/10.1002/(SICI)1099-0518(19980915)36:12<1995::AID-POLA4>3.0.CO;2-N
 [X]  - SCHNEERSON R. ET AL., "Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsulae of Bacillus anthracis: A potential addition to the anthrax vaccine", PNAS, (20030722), vol. 100, no. 15, pages 8945 - 8950, XP002306072

DOI:   http://dx.doi.org/10.1073/pnas.1633512100
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.